|
|
News Breaks | | | | February 12, 2013 | | 07:11 EDT |  | BSX | OrbusNeich announces favorable ruling from European Patent Office
OrbusNeich Medical announced that it received a favorable ruling from the European Patent Office yesterday in connection with its European Patent EP1 341 482. The '482 patent covers certain novel stents with helical structures. It was issued by the EPO to OrbusNeich in October 2010 and does not expire until December 2021. In July 2011, Boston Scientific Corporation and Terumo Kabushiki Kaisha filed oppositions asking the EPO to revoke the '482 patent, asserting that the patent was invalid. | |
|
News For BSX From The Last 14 Days Check below for free stories on BSX the last two weeks. |
|
|
| June 18, 2013 | | 05:23 EDT | | BSX | Boston Scientific Vercise DBS System demonstrates improvement in motor function
Patients with Parkinson's disease using the Boston Scientific Vercise DBS, or deep brain stimulation, System showed a significant improvement in motor scores according to interim data from the VANTAGE DBS study. The Vercise DBS System incorporates multiple independent current control, which is designed to selectively stimulate targeted areas in the brain, providing physicians with fine control of stimulation. Preliminary analysis of the VANTAGE study displays approximately 60% mean improvement in motor function at six months post implant, as assessed by UPDRS III when compared to baseline. | | | June 17, 2013 | | 17:04 EDT | | BSX | Boston Scientific begins patient enrollment in U.S. clinical trial for Vercise
 Subscribe for More Information | |
|
|
|
|
|
|
